Skip to main content
. 2020 Oct 4;16(8):838–850. doi: 10.1080/15592294.2020.1827723

Table 2.

Bisubstrate inhibitors of type A and B HATs

Compound
Inhibition (IC50)
  Type A HATs target Type B HATs target
H3-CoA-20 200 µM (p300) 0.3 µM (Kd 0.028) (PCAF)  
Lys-CoA 0.5 µM (Kd 0.019) (p300) 200 µM (PCAF)  
Lys-CoA 3.2 µM (p300)    
Lys-CoA 0.05 µM (p300)    
Lys-Phe-CoA 0.7 µM (p300)    
Lys-CoA-Me 0.8 µM (p300)    
Lys-CoA-3ʹ-dephospho 1.6 µM (p300)    
H4K5CoA     0.083 µM (HAT1)
H4K8CoA     2.6 µM (HAT1)
H4K12CoA     0.023 µM (HAT1)
H4K16CoA     7.2 µM (HAT1)